Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4890
+0.0120 (2.52%)
At close: Mar 26, 2026
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 33.24 million as of March 27, 2026. Its market cap has increased by 72.18% in one year.
Market Cap
33.24M
Enterprise Value
36.53M
Revenue
281.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 33.24M, an increase of 411.41%. That is a compound annual growth rate of 9.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 33.24M | 22.56% |
| Dec 30, 2025 | 27.12M | 2.84% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.68B |
| NEUCA | 3.21B |
| Synektik Spólka Akcyjna | 2.32B |
| Voxel | 1.16B |
| BioMaxima | 47.59M |
| Sygnis | 44.16M |
| Pharmena | 36.75M |
| Pure Biologics | 34.16M |